Skip to content
2000
Volume 6, Issue 14
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

The strategic use of fluorine substitution in drug discovery and drug development is well documented. The small size and high electronegativity of fluorine are among properties of this element that lend special advantages. Applications in drugs targeted to the central nervous system (CNS) have been particularly fruitful in addition to favorable properties seen in many peripherally acting drugs. Fluorine substitution can be used to solve problems unique to the CNS, such as blood brain barrier (BBB) penetration. Likewise, use of the positron emitting isotope, 18F, provides a unique tool for non-invasive imaging and diagnoses in the CNS. In this review, fluorine in CNS drugs and drug discovery are discussed.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/156802606777951046
2006-07-01
2025-09-15
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/156802606777951046
Loading

  • Article Type:
    Research Article
Keyword(s): CNS; drugs; Fluorine; imaging; PET
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test